ESRP1 and gastric cancer: We also observed that tumors with FGFR2 and ESRP1 genetic amplification presented increased RNA expression of the respective gene, supporting CN change as one of the mechanisms underlying FGFR2/ESRP1 signaling dysregulation in GC.